North America Cell Therapy Market Forecast 2022-2030
Description
North America Cell Therapy Market Forecast 2022-2030
KEY FINDINGS
The North America cell therapy market is set to project a CAGR of 14.13% during the forecast period, 2022-2030. The presence of companies like Kolon TissueGene, NuVasive Inc, Bristol-Myers Squibb Company, Gilead Sciences Inc, Vericel Corporation, etc., majorly contributes to market growth. However, the market growth is restrained by stringent regulations.
MARKET INSIGHTS
Canada and the United States are assessed for the North America cell therapy market growth analysis. In Canada, investments and funding by the government are targeted at enhancing the country's stem cell research ecosystem. Also, several stem cell-related clinical trials are underway in the country. In addition, the Canadian Stem Cell Foundation has established a Canadian Stem Cell Strategy and Action Plan for making Canada lucrative for more high-quality stem cell clinical trials.
Further, the presence of centers and institutions like the Centre for Commercialization of Regenerative Medicine (CCRM), the Ontario Institute for Regenerative Medicine, and the Ontario Stem Cell Institute, active in regenerative medicine and stem cells, is beneficial to market growth. Such developments are projected to increase growth opportunities.
COMPETITIVE INSIGHTS
Some of the key firms operating in the market include Anterogen Co Ltd, JCR Pharmaceuticals Co Ltd, Bristol Myers Squibb Company, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
KEY FINDINGS
The North America cell therapy market is set to project a CAGR of 14.13% during the forecast period, 2022-2030. The presence of companies like Kolon TissueGene, NuVasive Inc, Bristol-Myers Squibb Company, Gilead Sciences Inc, Vericel Corporation, etc., majorly contributes to market growth. However, the market growth is restrained by stringent regulations.
MARKET INSIGHTS
Canada and the United States are assessed for the North America cell therapy market growth analysis. In Canada, investments and funding by the government are targeted at enhancing the country's stem cell research ecosystem. Also, several stem cell-related clinical trials are underway in the country. In addition, the Canadian Stem Cell Foundation has established a Canadian Stem Cell Strategy and Action Plan for making Canada lucrative for more high-quality stem cell clinical trials.
Further, the presence of centers and institutions like the Centre for Commercialization of Regenerative Medicine (CCRM), the Ontario Institute for Regenerative Medicine, and the Ontario Stem Cell Institute, active in regenerative medicine and stem cells, is beneficial to market growth. Such developments are projected to increase growth opportunities.
COMPETITIVE INSIGHTS
Some of the key firms operating in the market include Anterogen Co Ltd, JCR Pharmaceuticals Co Ltd, Bristol Myers Squibb Company, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
145 Pages
- 1. Research Scope & Methodology
- 1.1. Study Objectives
- 1.2. Scope Of Study
- 1.3. Methodology
- 1.4. Assumptions & Limitations
- 2. Executive Summary
- 2.1. Market Size & Estimates
- 2.2. Market Overview
- 3. Market Dynamics
- 3.1. Key Drivers
- 3.1.1. Increasing Cellular Therapy Clinical Trials
- 3.1.2. Growth Of Regenerative Medicine
- 3.1.3. High Prevalence Of Chronic Diseases
- 3.2. Key Restraints
- 3.2.1. Increasing Skills Gap
- 3.2.2. High Costs
- 4. Key Analytics
- 4.1. Impact Of Covid-19 On Cell Therapy Market
- 4.2. Key Market Trends
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Buyers Power
- 4.3.2. Suppliers Power
- 4.3.3. Substitution
- 4.3.4. New Entrants
- 4.3.5. Industry Rivalry
- 4.4. Regulatory Framework
- 4.5. Opportunity Matrix
- 4.6. Vendor Landscape
- 5. Market By Cell Type
- 5.1. Stem Cell
- 5.1.1. Bone Marrow
- 5.1.2. Blood
- 5.1.3. Umbilical Cord-derived Stem Cell
- 5.1.4. Adipose-derived Stem Cell
- 5.1.5. Others
- 5.2. Non-stem Cell
- 6. Market By Therapy Type
- 6.1. Autologous
- 6.2. Allogeneic
- 7. Market By Therapeutic Application
- 7.1. Malignancies
- 7.2. Musculoskeletal Disorders
- 7.3. Autoimmune Disorders
- 7.4. Dermatology
- 7.5. Other Applications
- 8. Market By End-user
- 8.1. Hospitals & Clinics
- 8.2. Academic & Research Institutes
- 9. Geographical Analysis
- 9.1. North America
- 9.1.1. Market Size & Estimates
- 9.1.2. Key Drivers
- 9.1.3. Key Challenges
- 9.1.4. Key Players
- 9.1.5. Country Analysis
- 9.1.5.1. United States
- 9.1.5.2. Canada
- 10. Competitive Landscape
- 10.1. Key Strategic Developments
- 10.1.1. Mergers & Acquisitions
- 10.1.2. Product Launches & Developments
- 10.1.3. Partnerships & Agreements
- 10.1.4. Business Expansions
- 10.2. Company Profiles
- 10.2.1. Anterogen Co Ltd
- 10.2.2. Bristol Myers Squibb Company
- 10.2.3. Cells For Cells Sa
- 10.2.4. Gilead Sciences Inc
- 10.2.5. Jcr Pharmaceuticals Co Ltd
- 10.2.6. Kolon Tissuegene Inc
- 10.2.7. Medipost Co Ltd
- 10.2.8. Mesoblast Limited
- 10.2.9. Nuvasive Inc
- 10.2.10. Smith & Nephew Plc
- 10.2.11. Stemedica Cell Technologies Inc
- 10.2.12. Vericel Corporation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
